IP Library Patent Application 17245015
Patent Application
App. No. 17/245,015

SYSTEMS AND METHODS FOR DETECTION OF BIOLOGICAL AGENTS USING INFRARED SPECTROSCOPY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/245,015
Abstract

This application is generally related to methods, apparatuses and systems for rapid, sensitive detection of biological agents. One aspect is directed to a system including an infrared optical source configured to output an optical beam at a pulse repetition rate greater than or equal to 1 MHz. The system also includes a medium configured to receive the optical beam in first and second locations of the medium, where each of the first and second locations is separated by a barrier, the first location includes a solvent, and the second location includes a biological agent in the solvent. The system also includes a detector configured to receive the outputted optical beam from the medium and detect infrared spectra therefrom.

Claims (31)

1 . A system comprising:

an infrared optical source configured to output an optical beam at a pulse repetition rate greater than or equal to 1 MHz;

a medium configured to receive the optical beam in first and second locations of the medium, where each of the first and second locations is separated by a barrier, the first location incudes a solvent, and the second location includes a biological agent in the solvent; and

a detector configured to receive the outputted optical beam from the medium and detect infrared spectra therefrom.

2 . The system of claim 1 , further comprising a means for interferometrically subtracting a common mode of the received optical beam prior to the detection of infrared spectra.

3 . The system of claim 2 , wherein a rejection of the common mode ranges between about 20-30 dB.

4 . The system of claim 3 , exhibiting an improvement in a signal-to-noise ratio up to about 50 dB employing the infrared optical source in comparison to another system employing a black body radiation source.

5 . The system of claim 1 , wherein the pulse repetition rate is less than about 500 MHz.

6 . The system of claim 1 , wherein the optical beam is spatially coherent.

7 . The system of claim 1 , wherein the medium comprises a crystalline substrate and a metal film layer of about 10 to 100 nm thickness formed on the crystalline substrate.

8 . The system of claim 1 , wherein the medium includes plural hollow core fibers.

9 . The system of claim 1 , wherein the pulse repetition rate is greater than or equal to 10 GHz.

10 . A method comprising:

receiving, at a detector, an optical beam output from a medium via plural locations, where the optical beam enters the medium at a pulse repetition rate greater than or equal to 1 MHz, and travels through a first path including a solvent and a second path including the solvent and a biological agent;

evaluating spectra of the optical beam; and

determining information of a biological agent based upon the evaluated spectra.

11 . The method of claim 10 , further comprising:

interferometrically subtracting a common mode of the received optical beam prior to the evaluation of spectra.

12 . The method of claim 11 , wherein a rejection of the common mode is greater than about 20 dB.

13 . The method of claim 10 , further comprising:

detecting about 1-10 picograms of analytes from the biological agent.

14 . A computer readable medium including program instructions that, when executed by a processor of a computing device, causes the computing device to:

receive, via a spectrometer employing a Fourier Transform, spectra of an optical beam originating at a source and transmitted at a pulse repetition rate greater than or equal to 1 MHz through a medium including a solvent and a biological agent;

evaluate, via a trained machine learning model, one or more of attributes of the spectra to identify the biological agent; and

identify the biological agent based on at least a subset of the evaluated attributes.

15 . The computer readable medium of claim 14 , wherein the evaluation includes assigning each of the attributes a score based upon a likelihood of similarity with at least one respective attribute in training data used by the machine learning model.

16 . The computer readable medium of claim 14 , wherein the program instructions when executed by the processor further causes the computing device to transmit the identified biological agent over a network to another computing device.

17 . The computer readable medium of claim 14 , wherein interferometric subtraction of a common mode of the optical beam occurs prior to receiving the spectra.

18 . The computer readable medium of claim 17 , wherein a rejection of the common mode is greater than about 20 dB.

19 . The computer readable medium of claim 14 , wherein about 1-10 picograms of analytes of the biological agent are captured from the optical beam to produce the spectra.

20 . The computer readable medium of claim 14 , wherein the pulse repetition rate is less than about 500 MHz.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 22, 2025
From: CACI, INC. - FEDERAL
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069987/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2021
From: DINU, MIHAELA; HUDSON, DARREN DUANE; KANG, INUK
To: CACI, INC. - FEDERAL
Reel/Frame 056314/0914 →